1. Exploring a New Natural Treating Agent for Primary Hypertension: Recent Findings and Forthcoming Perspectives
   null Lin et al, 2019, JCM CrossRef
2. New Insights on the Beneficial Effects of the Probiotic Kefir on Vascular Dysfunction in Cardiovascular and Neurodegenerative Diseases
   Elisardo C. Vasquez et al, 2020, CPD CrossRef
3. Targeting Gut Microbiota to Treat Hypertension: A Systematic Review
   Joonatan Palmu et al, 2021, IJERPH CrossRef
4. Microbiome-Metabolomics Analysis Reveals the Protection Mechanism of α-Ketoacid on Adenine-Induced Chronic Kidney Disease in Rats
   Yenan Mo et al, 2021, Front. Pharmacol. CrossRef
5. Gut Microbiota Dysbiosis in Human Hypertension: A Systematic Review of Observational Studies
   Yang Guo et al, 2021, Front. Cardiovasc. Med. CrossRef
6. Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension.
   Hao-jie Zhong, 0 CrossRef
7. Potassium Alginate Oligosaccharides Alter Gut Microbiota, and Have Potential to Prevent the Development of Hypertension and Heart Failure in Spontaneously Hypertensive Rats
   Zhen-Lian Han et al, 2021, IJMS CrossRef
8. Comparison and Analysis of Gut Microbiota in Children With IgA Vasculitis With Different Clinical Symptoms
   Meng Li et al, 2022, Front. Pediatr. CrossRef
9. Why Do These Microbes Like Me and How Could There Be a Link with Cardiovascular Risk Factors?
   Emilia Sawicka-Śmiarowska et al, 2022, JCM CrossRef
10. Combination of Oxalobacter Formigenes and Veillonella Parvula in Gastrointestinal Microbiota Related to Bile-Acid Metabolism as a Biomarker for Hypertensive Nephropathy
    Xin Li et al, 2022, International Journal of Hypertension CrossRef
11. Intestinal microbiota composition of children with infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and multisystem inflammatory syndrome (MIS-C)
    Cansu Suskun et al, 2022, Eur J Pediatr CrossRef
12. A Possible Link between Gut Microbiome Composition and Cardiovascular Comorbidities in Psoriatic Patients
    Virginia Valentini et al, 2022, JPM CrossRef
13. Regulatory effect of gut microbes on blood pressure.
    Dong Yan et al, 2022, Animal Model Exp Med CrossRef
14. Eucommia ulmoides bark extract reduces blood pressure and inflammation by regulating the gut microbiota and enriching the Parabacteroides strain in high-salt diet and N(omega)-nitro-L-arginine methyl ester induced mice
    Dong Yan et al, 2022, Front. Microbiol. CrossRef
15. Association of Gut Microbial Dysbiosis and Hypertension: A Systematic Review
    Shaili S Naik et al, 2022 CrossRef
16. Washed microbiota transplantation improves patients with metabolic syndrome in South China
    Lei Wu et al, 2022, Front. Cell. Infect. Microbiol. CrossRef
17. Gut microbiota and hypertension: association, mechanisms and treatment
    Zhihua Yang et al, 2023, Clinical and Experimental Hypertension CrossRef
18. Analysis of Factors Associated with Constipation in the Population with Obesity: Evidence from the National Health and Nutrition Examination Survey
    Yongping Hong et al, 2024, Obes Facts CrossRef
19. Advancements in the Study of Polyphenols’ Impact on Hypertension and Their Mechanism Related to Gut Microbiota
    晓萌 凌, 2024, ACM CrossRef
20. Gut Microbiome and Neuroinflammation in Hypertension
    Elaine M. Richards et al, 2022, Circulation Research CrossRef
21. Research Progress on the Correlation Between Hypertension and Gut Microbiota
    Xiaomei Cui et al, 2024, JMDH CrossRef
22. Broadening horizons: intestinal microbiota as a novel biomarker and potential treatment for hypertensive disorders of pregnancy
    Min Wang et al, 2024, Front. Cell. Infect. Microbiol. CrossRef
23. Gut Microbiota Modulation by Selenium and Zinc Enrichment Postbiotic on Dysbiosis Associated with Hypertension
    Laura-Dorina Dinu et al, 2024, CVP CrossRef
24. An insight into probiotic microorganisms
    Archana Chaudhari et al, 2025 CrossRef